 | • レポートコード：GIR-107A12664 • 出版社/出版日：GlobalInfoResearch / 2021年7月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、呼吸器合胞体ウイルス診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。呼吸器合胞体ウイルス診断の種類別市場規模（直接蛍光抗体法、迅速抗原診断検査、分子診断、クロマトグラフィーイムノアッセイ、画像診断、ゲル微小液滴、フローサイトメトリー、その他）、用途別市場規模（病院、研究所、クリニック、在宅ケア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・呼吸器合胞体ウイルス診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Becton Dickinson、Abbott Laboratories、Abbott、Beckman Coulter/Danaher、Bio-Rad Laboratories、Coris BioConcept、DiaSorin SPA、Eiken Chemical、Elitech、Fujirebio、Grifols、Hoffmann La Roche、Hologic、Novartis Diagnostics、Ortho Clinical Diagnostics、Roche Diagnostics、Scienion ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：直接蛍光抗体法、迅速抗原診断検査、分子診断、クロマトグラフィーイムノアッセイ、画像診断、ゲル微小液滴、フローサイトメトリー、その他 ・用途別分析2016年-2026年：病院、研究所、クリニック、在宅ケア ・呼吸器合胞体ウイルス診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・呼吸器合胞体ウイルス診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・呼吸器合胞体ウイルス診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・呼吸器合胞体ウイルス診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・呼吸器合胞体ウイルス診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Respiratory Syncytial Virus Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Respiratory Syncytial Virus Diagnostics size is estimated to be USD 718.8 million in 2026 from USD 580.7 million in 2020, with a change XX% between 2020 and 2021. The global Respiratory Syncytial Virus Diagnostics market size is expected to grow at a CAGR of 5.5% for the next five years.
Market segmentation
Respiratory Syncytial Virus Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Direct Fluorescent Antibody Method
Rapid Antigen Diagnostic Tests
Molecular Diagnostics
Chromatographic Immunoassay
Diagnostic Imaging
Gel Microdroplets
Flow Cytometry
Other
Market segment by Application, can be divided into
Hospitals
Laboratory
Clinics
Homecare
Market segment by players, this report covers
Becton Dickinson
Abbott Laboratories
Abbott
Beckman Coulter/Danaher
Bio-Rad Laboratories
Coris BioConcept
DiaSorin SPA
Eiken Chemical
Elitech
Fujirebio
Grifols
Hoffmann La Roche
Hologic
Novartis Diagnostics
Ortho Clinical Diagnostics
Roche Diagnostics
Scienion
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Respiratory Syncytial Virus Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Respiratory Syncytial Virus Diagnostics, with revenue, gross margin and global market share of Respiratory Syncytial Virus Diagnostics from 2019 to 2021.
Chapter 3, the Respiratory Syncytial Virus Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Respiratory Syncytial Virus Diagnostics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Respiratory Syncytial Virus Diagnostics research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Respiratory Syncytial Virus Diagnostics
1.2 Classification of Respiratory Syncytial Virus Diagnostics by Type
1.2.1 Overview: Global Respiratory Syncytial Virus Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Type in 2020
1.2.3 Direct Fluorescent Antibody Method
1.2.4 Rapid Antigen Diagnostic Tests
1.2.5 Molecular Diagnostics
1.2.6 Chromatographic Immunoassay
1.2.7 Diagnostic Imaging
1.2.8 Gel Microdroplets
1.2.9 Flow Cytometry
1.2.10 Other
1.3 Global Respiratory Syncytial Virus Diagnostics Market by Application
1.3.1 Overview: Global Respiratory Syncytial Virus Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Laboratory
1.3.4 Clinics
1.3.5 Homecare
1.4 Global Respiratory Syncytial Virus Diagnostics Market Size & Forecast
1.5 Global Respiratory Syncytial Virus Diagnostics Market Size and Forecast by Region
1.5.1 Global Respiratory Syncytial Virus Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Respiratory Syncytial Virus Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America Respiratory Syncytial Virus Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe Respiratory Syncytial Virus Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America Respiratory Syncytial Virus Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Respiratory Syncytial Virus Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Respiratory Syncytial Virus Diagnostics Market Drivers
1.6.2 Respiratory Syncytial Virus Diagnostics Market Restraints
1.6.3 Respiratory Syncytial Virus Diagnostics Trends Analysis
2 Company Profiles
2.1 Becton Dickinson
2.1.1 Becton Dickinson Details
2.1.2 Becton Dickinson Major Business
2.1.3 Becton Dickinson Respiratory Syncytial Virus Diagnostics Product and Solutions
2.1.4 Becton Dickinson Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Becton Dickinson Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Respiratory Syncytial Virus Diagnostics Product and Solutions
2.2.4 Abbott Laboratories Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Respiratory Syncytial Virus Diagnostics Product and Solutions
2.3.4 Abbott Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Abbott Recent Developments and Future Plans
2.4 Beckman Coulter/Danaher
2.4.1 Beckman Coulter/Danaher Details
2.4.2 Beckman Coulter/Danaher Major Business
2.4.3 Beckman Coulter/Danaher Respiratory Syncytial Virus Diagnostics Product and Solutions
2.4.4 Beckman Coulter/Danaher Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Beckman Coulter/Danaher Recent Developments and Future Plans
2.5 Bio-Rad Laboratories
2.5.1 Bio-Rad Laboratories Details
2.5.2 Bio-Rad Laboratories Major Business
2.5.3 Bio-Rad Laboratories Respiratory Syncytial Virus Diagnostics Product and Solutions
2.5.4 Bio-Rad Laboratories Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.6 Coris BioConcept
2.6.1 Coris BioConcept Details
2.6.2 Coris BioConcept Major Business
2.6.3 Coris BioConcept Respiratory Syncytial Virus Diagnostics Product and Solutions
2.6.4 Coris BioConcept Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Coris BioConcept Recent Developments and Future Plans
2.7 DiaSorin SPA
2.7.1 DiaSorin SPA Details
2.7.2 DiaSorin SPA Major Business
2.7.3 DiaSorin SPA Respiratory Syncytial Virus Diagnostics Product and Solutions
2.7.4 DiaSorin SPA Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 DiaSorin SPA Recent Developments and Future Plans
2.8 Eiken Chemical
2.8.1 Eiken Chemical Details
2.8.2 Eiken Chemical Major Business
2.8.3 Eiken Chemical Respiratory Syncytial Virus Diagnostics Product and Solutions
2.8.4 Eiken Chemical Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Eiken Chemical Recent Developments and Future Plans
2.9 Elitech
2.9.1 Elitech Details
2.9.2 Elitech Major Business
2.9.3 Elitech Respiratory Syncytial Virus Diagnostics Product and Solutions
2.9.4 Elitech Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Elitech Recent Developments and Future Plans
2.10 Fujirebio
2.10.1 Fujirebio Details
2.10.2 Fujirebio Major Business
2.10.3 Fujirebio Respiratory Syncytial Virus Diagnostics Product and Solutions
2.10.4 Fujirebio Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Fujirebio Recent Developments and Future Plans
2.11 Grifols
2.11.1 Grifols Details
2.11.2 Grifols Major Business
2.11.3 Grifols Respiratory Syncytial Virus Diagnostics Product and Solutions
2.11.4 Grifols Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Grifols Recent Developments and Future Plans
2.12 Hoffmann La Roche
2.12.1 Hoffmann La Roche Details
2.12.2 Hoffmann La Roche Major Business
2.12.3 Hoffmann La Roche Respiratory Syncytial Virus Diagnostics Product and Solutions
2.12.4 Hoffmann La Roche Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Hoffmann La Roche Recent Developments and Future Plans
2.13 Hologic
2.13.1 Hologic Details
2.13.2 Hologic Major Business
2.13.3 Hologic Respiratory Syncytial Virus Diagnostics Product and Solutions
2.13.4 Hologic Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Hologic Recent Developments and Future Plans
2.14 Novartis Diagnostics
2.14.1 Novartis Diagnostics Details
2.14.2 Novartis Diagnostics Major Business
2.14.3 Novartis Diagnostics Respiratory Syncytial Virus Diagnostics Product and Solutions
2.14.4 Novartis Diagnostics Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Novartis Diagnostics Recent Developments and Future Plans
2.15 Ortho Clinical Diagnostics
2.15.1 Ortho Clinical Diagnostics Details
2.15.2 Ortho Clinical Diagnostics Major Business
2.15.3 Ortho Clinical Diagnostics Respiratory Syncytial Virus Diagnostics Product and Solutions
2.15.4 Ortho Clinical Diagnostics Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Ortho Clinical Diagnostics Recent Developments and Future Plans
2.16 Roche Diagnostics
2.16.1 Roche Diagnostics Details
2.16.2 Roche Diagnostics Major Business
2.16.3 Roche Diagnostics Respiratory Syncytial Virus Diagnostics Product and Solutions
2.16.4 Roche Diagnostics Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Roche Diagnostics Recent Developments and Future Plans
2.17 Scienion
2.17.1 Scienion Details
2.17.2 Scienion Major Business
2.17.3 Scienion Respiratory Syncytial Virus Diagnostics Product and Solutions
2.17.4 Scienion Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Scienion Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Respiratory Syncytial Virus Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Respiratory Syncytial Virus Diagnostics Players Market Share
3.2.2 Top 10 Respiratory Syncytial Virus Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 Respiratory Syncytial Virus Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Respiratory Syncytial Virus Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global Respiratory Syncytial Virus Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Application (2016-2021)
5.2 Respiratory Syncytial Virus Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Respiratory Syncytial Virus Diagnostics Revenue by Type (2016-2026)
6.2 North America Respiratory Syncytial Virus Diagnostics Revenue by Application (2016-2026)
6.3 North America Respiratory Syncytial Virus Diagnostics Market Size by Country
6.3.1 North America Respiratory Syncytial Virus Diagnostics Revenue by Country (2016-2026)
6.3.2 United States Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Respiratory Syncytial Virus Diagnostics Revenue by Type (2016-2026)
7.2 Europe Respiratory Syncytial Virus Diagnostics Revenue by Application (2016-2026)
7.3 Europe Respiratory Syncytial Virus Diagnostics Market Size by Country
7.3.1 Europe Respiratory Syncytial Virus Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Respiratory Syncytial Virus Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific Respiratory Syncytial Virus Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Region
8.3.1 Asia-Pacific Respiratory Syncytial Virus Diagnostics Revenue by Region (2016-2026)
8.3.2 China Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Respiratory Syncytial Virus Diagnostics Revenue by Type (2016-2026)
9.2 South America Respiratory Syncytial Virus Diagnostics Revenue by Application (2016-2026)
9.3 South America Respiratory Syncytial Virus Diagnostics Market Size by Country
9.3.1 South America Respiratory Syncytial Virus Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Respiratory Syncytial Virus Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa Respiratory Syncytial Virus Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Country
10.3.1 Middle East & Africa Respiratory Syncytial Virus Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Respiratory Syncytial Virus Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Respiratory Syncytial Virus Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Respiratory Syncytial Virus Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Respiratory Syncytial Virus Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. Becton Dickinson Corporate Information, Head Office, and Major Competitors
Table 7. Becton Dickinson Major Business
Table 8. Becton Dickinson Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 9. Becton Dickinson Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 13. Abbott Laboratories Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Abbott Corporate Information, Head Office, and Major Competitors
Table 15. Abbott Major Business
Table 16. Abbott Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 17. Abbott Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Beckman Coulter/Danaher Corporate Information, Head Office, and Major Competitors
Table 19. Beckman Coulter/Danaher Major Business
Table 20. Beckman Coulter/Danaher Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 21. Beckman Coulter/Danaher Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 23. Bio-Rad Laboratories Major Business
Table 24. Bio-Rad Laboratories Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 25. Bio-Rad Laboratories Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Coris BioConcept Corporate Information, Head Office, and Major Competitors
Table 27. Coris BioConcept Major Business
Table 28. Coris BioConcept Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 29. Coris BioConcept Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. DiaSorin SPA Corporate Information, Head Office, and Major Competitors
Table 31. DiaSorin SPA Major Business
Table 32. DiaSorin SPA Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 33. DiaSorin SPA Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Eiken Chemical Corporate Information, Head Office, and Major Competitors
Table 35. Eiken Chemical Major Business
Table 36. Eiken Chemical Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 37. Eiken Chemical Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Elitech Corporate Information, Head Office, and Major Competitors
Table 39. Elitech Major Business
Table 40. Elitech Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 41. Elitech Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Fujirebio Corporate Information, Head Office, and Major Competitors
Table 43. Fujirebio Major Business
Table 44. Fujirebio Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 45. Fujirebio Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Grifols Corporate Information, Head Office, and Major Competitors
Table 47. Grifols Major Business
Table 48. Grifols Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 49. Grifols Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Hoffmann La Roche Corporate Information, Head Office, and Major Competitors
Table 51. Hoffmann La Roche Major Business
Table 52. Hoffmann La Roche Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 53. Hoffmann La Roche Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Hologic Corporate Information, Head Office, and Major Competitors
Table 55. Hologic Major Business
Table 56. Hologic Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 57. Hologic Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Novartis Diagnostics Corporate Information, Head Office, and Major Competitors
Table 59. Novartis Diagnostics Major Business
Table 60. Novartis Diagnostics Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 61. Novartis Diagnostics Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Ortho Clinical Diagnostics Corporate Information, Head Office, and Major Competitors
Table 63. Ortho Clinical Diagnostics Major Business
Table 64. Ortho Clinical Diagnostics Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 65. Ortho Clinical Diagnostics Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Roche Diagnostics Corporate Information, Head Office, and Major Competitors
Table 67. Roche Diagnostics Major Business
Table 68. Roche Diagnostics Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 69. Roche Diagnostics Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Scienion Corporate Information, Head Office, and Major Competitors
Table 71. Scienion Major Business
Table 72. Scienion Respiratory Syncytial Virus Diagnostics Product and Solutions
Table 73. Scienion Respiratory Syncytial Virus Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Global Respiratory Syncytial Virus Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 75. Global Respiratory Syncytial Virus Diagnostics Revenue Share by Players (2019-2021)
Table 76. Breakdown of Respiratory Syncytial Virus Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Respiratory Syncytial Virus Diagnostics Players Head Office, Products and Services Provided
Table 78. Respiratory Syncytial Virus Diagnostics Mergers & Acquisitions in the Past Five Years
Table 79. Respiratory Syncytial Virus Diagnostics New Entrants and Expansion Plans
Table 80. Global Respiratory Syncytial Virus Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 81. Global Respiratory Syncytial Virus Diagnostics Revenue Share by Type (2016-2021)
Table 82. Global Respiratory Syncytial Virus Diagnostics Revenue Forecast by Type (2021-2026)
Table 83. Global Respiratory Syncytial Virus Diagnostics Revenue by Application (2016-2021)
Table 84. Global Respiratory Syncytial Virus Diagnostics Revenue Forecast by Application (2021-2026)
Table 85. North America Respiratory Syncytial Virus Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 86. North America Respiratory Syncytial Virus Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 87. North America Respiratory Syncytial Virus Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 88. North America Respiratory Syncytial Virus Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 89. North America Respiratory Syncytial Virus Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 90. North America Respiratory Syncytial Virus Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 91. Europe Respiratory Syncytial Virus Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 92. Europe Respiratory Syncytial Virus Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 93. Europe Respiratory Syncytial Virus Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 94. Europe Respiratory Syncytial Virus Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 95. Europe Respiratory Syncytial Virus Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 96. Europe Respiratory Syncytial Virus Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 97. Asia-Pacific Respiratory Syncytial Virus Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 98. Asia-Pacific Respiratory Syncytial Virus Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 99. Asia-Pacific Respiratory Syncytial Virus Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 100. Asia-Pacific Respiratory Syncytial Virus Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 101. Asia-Pacific Respiratory Syncytial Virus Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 102. Asia-Pacific Respiratory Syncytial Virus Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 103. South America Respiratory Syncytial Virus Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 104. South America Respiratory Syncytial Virus Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 105. South America Respiratory Syncytial Virus Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 106. South America Respiratory Syncytial Virus Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 107. South America Respiratory Syncytial Virus Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 108. South America Respiratory Syncytial Virus Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 109. Middle East & Africa Respiratory Syncytial Virus Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 110. Middle East & Africa Respiratory Syncytial Virus Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 111. Middle East & Africa Respiratory Syncytial Virus Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 112. Middle East & Africa Respiratory Syncytial Virus Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 113. Middle East & Africa Respiratory Syncytial Virus Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 114. Middle East & Africa Respiratory Syncytial Virus Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Respiratory Syncytial Virus Diagnostics Picture
Figure 2. Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Type in 2020
Figure 3. Direct Fluorescent Antibody Method
Figure 4. Rapid Antigen Diagnostic Tests
Figure 5. Molecular Diagnostics
Figure 6. Chromatographic Immunoassay
Figure 7. Diagnostic Imaging
Figure 8. Gel Microdroplets
Figure 9. Flow Cytometry
Figure 10. Other
Figure 11. Respiratory Syncytial Virus Diagnostics Revenue Market Share by Application in 2020
Figure 12. Hospitals Picture
Figure 13. Laboratory Picture
Figure 14. Clinics Picture
Figure 15. Homecare Picture
Figure 16. Global Respiratory Syncytial Virus Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 17. Global Respiratory Syncytial Virus Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 18. Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Region (2016-2026)
Figure 19. Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Region in 2020
Figure 20. North America Respiratory Syncytial Virus Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Europe Respiratory Syncytial Virus Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Asia-Pacific Respiratory Syncytial Virus Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. South America Respiratory Syncytial Virus Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Middle East and Africa Respiratory Syncytial Virus Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. Respiratory Syncytial Virus Diagnostics Market Drivers
Figure 26. Respiratory Syncytial Virus Diagnostics Market Restraints
Figure 27. Respiratory Syncytial Virus Diagnostics Market Trends
Figure 28. Becton Dickinson Recent Developments and Future Plans
Figure 29. Abbott Laboratories Recent Developments and Future Plans
Figure 30. Abbott Recent Developments and Future Plans
Figure 31. Beckman Coulter/Danaher Recent Developments and Future Plans
Figure 32. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 33. Coris BioConcept Recent Developments and Future Plans
Figure 34. DiaSorin SPA Recent Developments and Future Plans
Figure 35. Eiken Chemical Recent Developments and Future Plans
Figure 36. Elitech Recent Developments and Future Plans
Figure 37. Fujirebio Recent Developments and Future Plans
Figure 38. Grifols Recent Developments and Future Plans
Figure 39. Hoffmann La Roche Recent Developments and Future Plans
Figure 40. Hologic Recent Developments and Future Plans
Figure 41. Novartis Diagnostics Recent Developments and Future Plans
Figure 42. Ortho Clinical Diagnostics Recent Developments and Future Plans
Figure 43. Roche Diagnostics Recent Developments and Future Plans
Figure 44. Scienion Recent Developments and Future Plans
Figure 45. Global Respiratory Syncytial Virus Diagnostics Revenue Share by Players in 2020
Figure 46. Respiratory Syncytial Virus Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 47. Global Top 3 Players Respiratory Syncytial Virus Diagnostics Revenue Market Share in 2020
Figure 48. Global Top 10 Players Respiratory Syncytial Virus Diagnostics Revenue Market Share in 2020
Figure 49. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 50. Global Respiratory Syncytial Virus Diagnostics Revenue Share by Type in 2020
Figure 51. Global Respiratory Syncytial Virus Diagnostics Market Share Forecast by Type (2021-2026)
Figure 52. Global Respiratory Syncytial Virus Diagnostics Revenue Share by Application in 2020
Figure 53. Global Respiratory Syncytial Virus Diagnostics Market Share Forecast by Application (2021-2026)
Figure 54. North America Respiratory Syncytial Virus Diagnostics Sales Market Share by Type (2016-2026)
Figure 55. North America Respiratory Syncytial Virus Diagnostics Sales Market Share by Application (2016-2026)
Figure 56. North America Respiratory Syncytial Virus Diagnostics Revenue Market Share by Country (2016-2026)
Figure 57. United States Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Canada Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Mexico Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Europe Respiratory Syncytial Virus Diagnostics Sales Market Share by Type (2016-2026)
Figure 61. Europe Respiratory Syncytial Virus Diagnostics Sales Market Share by Application (2016-2026)
Figure 62. Europe Respiratory Syncytial Virus Diagnostics Revenue Market Share by Country (2016-2026)
Figure 63. Germany Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. France Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. United Kingdom Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Russia Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Italy Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Asia-Pacific Respiratory Syncytial Virus Diagnostics Sales Market Share by Type (2016-2026)
Figure 69. Asia-Pacific Respiratory Syncytial Virus Diagnostics Sales Market Share by Application (2016-2026)
Figure 70. Asia-Pacific Respiratory Syncytial Virus Diagnostics Revenue Market Share by Region (2016-2026)
Figure 71. China Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Japan Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. South Korea Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. India Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Southeast Asia Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Australia Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South America Respiratory Syncytial Virus Diagnostics Sales Market Share by Type (2016-2026)
Figure 78. South America Respiratory Syncytial Virus Diagnostics Sales Market Share by Application (2016-2026)
Figure 79. South America Respiratory Syncytial Virus Diagnostics Revenue Market Share by Country (2016-2026)
Figure 80. Brazil Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Argentina Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Middle East and Africa Respiratory Syncytial Virus Diagnostics Sales Market Share by Type (2016-2026)
Figure 83. Middle East and Africa Respiratory Syncytial Virus Diagnostics Sales Market Share by Application (2016-2026)
Figure 84. Middle East and Africa Respiratory Syncytial Virus Diagnostics Revenue Market Share by Country (2016-2026)
Figure 85. Turkey Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. Saudi Arabia Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 87. UAE Respiratory Syncytial Virus Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 88. Methodology
Figure 89. Research Process and Data Source